Welcome to mydermzone.com - Dermatology Resource Center - CME - dermatologic diseases, disease states, treatment options, patient management Welcome to mydermzone.com - Dermatology Resource Center - CME - dermatologic diseases, disease states, treatment options, patient management Clinical Reflections on Facial Aging Welcome to mydermzone.com - Dermatology Resource Center - CME - dermatologic diseases, disease states, treatment options, patient management
  PROGRAM FACULTY
W. Philip Werschler, MD, FAAD, FAACS Assistant Clinical Professor of Medicine/Dermatology
Faculty Chairman
University of Washington School of Medicine
Seattle, WA
Click on Published Articles for a list of published articles by Dr. W. Philip Werschler
Rebecca Fitzgerald, MD
Faculty Chairman
Cosmetic and Clinical Dermatology; Clinical Instructor, David Geffen School of Medicine at UCLA
Los Angeles, CA


CME Programs
WHAT LIES BENEATH: Taking a Deeper Look at Acne & Patient Care Strategies
To register for this program, please click here.
WHAT LIES BENEATH: Taking a Deeper Look at Acne & Patient Care Strategies - <P class=MsoNormal style...

A Non-Surgical Total Facial Rejuvenation: The Role of Bio-Stimulatory Agents
To participate in this program, please click here.
W. Philip Werschler, , MD, FAAD, FAACS, Assistant Clinical Professor of Medicine/Dermatology
A Non-Surgical Total Facial Rejuvenation: The Role of Bio-Stimulatory Agents - W. Philip  Werschler,...

Digital Imaging: Improving Dermatology Patient Care Through Technology
To participate in this program, please click here.
Digital Imaging: Improving Dermatology Patient Care Through Technology -  

Facial Restoration: Combining Therapies for Optimal Patient Outcomes
To participate in this webcast, please click here.
Facial Restoration: Combining Therapies for Optimal Patient Outcomes

Medical Technology: Cornerstone to a Successful Dermatology Practice
To participate in this program, please click here.
Medical Technology: Cornerstone to a Successful Dermatology Practice - Experts from Physicians P...

Actinic Keratoses: What You Must Know About Prevention, Diagnosis, And Treatment
To participate in this program, please click here.
Actinic Keratoses: What You Must Know About Prevention, Diagnosis, And Treatment - This Johns Hopkin...

Not Just a Cosmetic Problem: Best Practices in Prevention and Treatment of Onychomycosis

The Office of Continuing Medical Education at Johns Hopkins University School of Medicine offers Johns Hopkins Advanced Studies in Medicine: Dermatology


To participate in this program, please click here.
Not Just a Cosmetic Problem: Best Practices in Prevention and Treatment of Onychomycosis - This John...

INTERACTIVE Grand Rounds: Best Practices for Actinic Keratosis
To participate in this program, please click here.
W. Philip Werschler, , MD, FAAD, FAACS, Assistant Clinical Professor of Medicine/Dermatology
INTERACTIVE Grand Rounds: Best Practices for Actinic Keratosis - W. Philip  Werschler, , MD, FAAD, F...


  FEATURED PROGRAM Feautured program
Not Just a Cosmetic Problem: Best Practices in Prevention and Treatment of Onychomycosis

The Office of Continuing Medical Education at Johns Hopkins University School of Medicine offers Johns Hopkins Advanced Studies in Medicine: Dermatology


Dermatology Grand Rounds: Best Practices for Actinic Keratosis

Skin cancer is the most common of human cancers, accounting for approximately 50% of all cancer cases, or more than 1 million new cases per year in the United States.  Approximately 50% of Americans who live to the age of 65 develop at least 1 skin cancer.  Nonmelanoma skin cancers, which include basal cell carcinoma and squamous cell carcinoma (SCC), account for more than 33% of all cancer cases in the United States.  The incidence of SCC increased by approximately 4% to 8% per year from the 1960s through the 1980s and has continued to increase during the past 2 decades.


  DID YOU KNOW?
Each of the following statements is true regarding use and injection technique of PLLA EXCEPT:
  A. The technique differs according to the area treated and the severity
  B. PLLA should not be used in subcutaneous layers or in the deep dermis
  C. The underlying and neighboring regions, rather than wrinkles or folds,
  D. Overcorrection of facial lipoatrophy should be avoided

  AAD ABSTRACTS AAD Abstracts
2008 Annual Meeting Poster Abstracts
TODAY'S NEWS
Today's News
Protective effect of caffeine against UV damage clarified
NEW YORK (Reuters Health) - New research suggests that caffeine protects human keratinocytes from UV damage and does this, at least in part, by inhibiting the ATR-Chk1 pathway. In murine studies, both oral and topical caffeine have been found to induce ap...
Protective effect of caffeine against UV damage clarified   - NEW YORK (Reuters Hea...
Ovulation induction associated with increased cancer risk
NEW YORK (Reuters Health) - Treatments used to induce ovulation appear to increase the overall risk of cancer, results of a study published in the February 1st issue of the American Journal of Epidemiology suggest."Ovulation-inducing drugs are widely used...
Ovulation induction associated with increased cancer risk - NEW YORK (Reuters Healt...
Nail dystrophy a predictor of psoriatic arthritis in psoriasis patients
NEW YORK (Reuters Health) - Less than 10% of psoriasis patients develop psoriatic arthritis during their lifetime, according to results of a study published in the February 15th issue of Arthritis and Rheumatism. Clinical predictors of psoriatic arthriti...
Nail dystrophy a predictor of psoriatic arthritis in psoriasis patients  - NEW YORK...
MEDLINE SEARCH
 advanced search
  Conference   Coverage Conference Coverage
The Dermatology Report: 4th Annual Advances in Cosmetic and Medical Dermatology Meeting
Dermatologic diseases range from annoying rashes to potentially life-threatening skin infections and malignant melanoma. This issue of The Dermatology Report is based on the 4th annual Advances in Cosmetic and Medical Dermatology meeting, held in Wailea, Maui, Hawaii, from February 25 to March 1, 2008.
  Survey Survey

What proportion of your patients visit for elective (vs. medical) treatment?

  A. 0 – 20%
  B. 20 – 40%
  C. 40 – 60%
  D. 60 – 80%
  E. 80 – 100%

  Supplements Supplements
Acne and Your Pediatric Patient: A Roundtable Discussion of Treatment Modalities and Other Factors
Which Options When: How to Maximize the Treatment Outcomes for Actinic Keratosis
Onychomycosis: Management and Treatment
Topical Treatment for the Inflamed Lesion in Acne, Rosacea, and Pseudofolliculitis Barbae
The BEST Study: Improving Satisfaction and Efficacy in Patients With Multiple Grades of Acne Who Are Dissatisfied With Their Current Acne Treatment